Search | VHL Search Portal

1.

Leukaemogenesis induced by an activating ß-catenin mutation in osteoblasts.

Kode, Aruna; Manavalan, John S; Mosialou, Ioanna; Bhagat, Govind; Rathinam, Chozha V; Luo, Na; Khiabanian, Hossein; Lee, Albert; Murty, Vundavalli V; Friedman, Richard; Brum, Andrea; Park, David; Galili, Naomi; Mukherjee, Siddhartha; Teruya-Feldstein, Julie; Raza, Azra; Rabadan, Raul; Berman, Ellin; Kousteni, Stavroula.

Nature ; 506(7487): 240-4, 2014 Feb 13.

Article in English | MEDLINE | ID: mdl-24429522

2.

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts.

Krevvata, Maria; Silva, Barbara C; Manavalan, John S; Galan-Diez, Marta; Kode, Aruna; Matthews, Brya Grace; Park, David; Zhang, Chiyuan A; Galili, Naomi; Nickolas, Thomas L; Dempster, David W; Dougall, William; Teruya-Feldstein, Julie; Economides, Aris N; Kalajzic, Ivo; Raza, Azra; Berman, Ellin; Mukherjee, Siddhartha; Bhagat, Govind; Kousteni, Stavroula.

Blood ; 124(18): 2834-46, 2014 Oct 30.

Article in English | MEDLINE | ID: mdl-25139351

3.

Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo.

Hu, Jingping; Liu, Jing; Xue, Fumin; Halverson, Gregory; Reid, Marion; Guo, Anqi; Chen, Lixiang; Raza, Azra; Galili, Naomi; Jaffray, Julie; Lane, Joseph; Chasis, Joel Anne; Taylor, Naomi; Mohandas, Narla; An, Xiuli.

Blood ; 121(16): 3246-53, 2013 Apr 18.

Article in English | MEDLINE | ID: mdl-23422750

4.

Clinical effect of point mutations in myelodysplastic syndromes.

Bejar, Rafael; Stevenson, Kristen; Abdel-Wahab, Omar; Galili, Naomi; Nilsson, Björn; Garcia-Manero, Guillermo; Kantarjian, Hagop; Raza, Azra; Levine, Ross L; Neuberg, Donna; Ebert, Benjamin L.

N Engl J Med ; 364(26): 2496-506, 2011 Jun 30.

Article in English | MEDLINE | ID: mdl-21714648

5.

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Ebert, Benjamin L; Pretz, Jennifer; Bosco, Jocelyn; Chang, Cindy Y; Tamayo, Pablo; Galili, Naomi; Raza, Azra; Root, David E; Attar, Eyal; Ellis, Steven R; Golub, Todd R.

Nature ; 451(7176): 335-9, 2008 Jan 17.

Article in English | MEDLINE | ID: mdl-18202658

6.

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome.

Kumar, Madhu S; Narla, Anupama; Nonami, Atsushi; Mullally, Ann; Dimitrova, Nadya; Ball, Brian; McAuley, J Randall; Poveromo, Luke; Kutok, Jeffrey L; Galili, Naomi; Raza, Azra; Attar, Eyal; Gilliland, D Gary; Jacks, Tyler; Ebert, Benjamin L.

Blood ; 118(17): 4666-73, 2011 Oct 27.

Article in English | MEDLINE | ID: mdl-21873545

7.

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.

Raza, Azra; Galili, Naomi; Smith, Scott E; Godwin, John; Boccia, Ralph V; Myint, Han; Mahadevan, Daruka; Mulford, Deborah; Rarick, Mark; Brown, Gail L; Schaar, Dale; Faderl, Stefan; Komrokji, Rami S; List, Alan F; Sekeres, Mikkael.

Cancer ; 118(8): 2138-47, 2012 Apr 15.

Article in English | MEDLINE | ID: mdl-21887679

8.

Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.

Ma, Xiaomei; Wang, Rong; Galili, Naomi; Mayne, Susan T; Wang, Sa A; Yu, Herbert; Raza, Azra.

Cancer Causes Control ; 22(4): 623-9, 2011 Apr.

Article in English | MEDLINE | ID: mdl-21287258

9.

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.

Raza, Azra; Galili, Naomi; Smith, Scott; Godwin, John; Lancet, Jeffrey; Melchert, Magda; Jones, Marsha; Keck, James G; Meng, Lisa; Brown, Gail L; List, Alan.

Blood ; 113(26): 6533-40, 2009 Jun 25.

Article in English | MEDLINE | ID: mdl-19398716

10.

Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).

Markus, Jan; Garin, Matthew T; Bies, Juraj; Galili, Naomi; Raza, Azra; Thirman, Michael J; Le Beau, Michelle M; Rowley, Janet D; Liu, P Paul; Wolff, Linda.

Cancer Res ; 67(3): 992-1000, 2007 Feb 01.

Article in English | MEDLINE | ID: mdl-17283131

11.

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome.

Ebert, Benjamin L; Galili, Naomi; Tamayo, Pablo; Bosco, Jocelyn; Mak, Raymond; Pretz, Jennifer; Tanguturi, Shyam; Ladd-Acosta, Christine; Stone, Richard; Golub, Todd R; Raza, Azra.

PLoS Med ; 5(2): e35, 2008 Feb.

Article in English | MEDLINE | ID: mdl-18271621

12.

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

Yue, Gang; Hao, Suyang; Fadare, Oluwole; Baker, Stephen; Pozdnyakova, Olga; Galili, Naomi; Woda, Bruce A; Raza, Azra; Wang, Sa A.

Leuk Res ; 32(4): 553-8, 2008 Apr.

Article in English | MEDLINE | ID: mdl-17888511

13.

The biology and treatment of myelodysplastic syndromes.

Raza, Azra; Galili, Naomi.

Rinsho Ketsueki ; 54(10): 1730-6, 2013 Oct.

Article in English | MEDLINE | ID: mdl-24064823

14.

Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes.

Ali, Abdullah Mahmood; Huang, Yumin; Pinheiro, Ronald Feitosa; Xue, Fumin; Hu, Jingping; Iverson, Nicholas; Hoehn, Daniela; Coutinho, Diego; Kayani, Jehanzeb; Chernak, Brian; Lane, Joseph; Hillyer, Christopher; Galili, Naomi; Jurcic, Joseph; Mohandas, Narla; An, Xiuli; Raza, Azra.

Blood Adv ; 2(12): 1393-1402, 2018 06 26.

Article in English | MEDLINE | ID: mdl-29903708

15.

Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.

Galili, Naomi; Sechman, Eric V; Cerny, Jan; Mehdi, Murtaza; Mumtaz, Muhammad; Westervelt, Peter; Maguire, Jessica; Raza, Azra.

Leuk Res ; 31(1): 19-26, 2007 Jan.

Article in English | MEDLINE | ID: mdl-17064768

16.

Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

Wang, Sa A; Galili, Naomi; Cerny, Jan; Sechman, Eric; Chen, Su Sin; Loew, Jerome; Liu, Qin; Fadare, Oluwole; Hasserjian, Robert; Jones, Dan; Qawi, Huma; Woda, Bruce; Raza, Azra.

Am J Clin Pathol ; 126(5): 789-97, 2006 Nov.

Article in English | MEDLINE | ID: mdl-17050076

17.

Phase II study of topotecan and thalidomide in patients with high-risk myelodysplastic syndromes.

Raza, Azra; Lisak, Laurie; Billmeier, Jennifer; Pervaiz, Hassan; Mumtaz, Muhammad; Gohar, Samreen; Wahid, Khalid; Galili, Naomi.

Leuk Lymphoma ; 47(3): 433-40, 2006 Mar.

Article in English | MEDLINE | ID: mdl-16396766

18.

Targeted therapies in myelodysplastic syndromes: ASH 2003 review.

Candoni, Anna; Silvestri, Federico; Buonamici, Silvia; Li, Donglan; Reddy, Poloru; Galili, Naomi; Nucifora, Giuseppina; Raza, Azra.

Semin Hematol ; 41(2 Suppl 4): 13-20, 2004 Apr.

Article in English | MEDLINE | ID: mdl-15190511

19.

A novel method for single cell detection of in situ telomerase or histone H3 in combination with clonal analysis by FISH.

Gladstone, Betty; Sivaraman, Smitha; Galili, Naomi; Venugopal, Parameswaran; Janssen, Imke; Nayini, Jaya; Yang, Jie; Hsu, Wei-Tong; Raza, Azra; Preisler, Harvey D.

Leuk Res ; 27(6): 529-37, 2003 Jun.

Article in English | MEDLINE | ID: mdl-12648513

20.

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

Raza, Azra; Buonamici, Silvia; Lisak, Laurie; Tahir, Sarah; Li, Donglan; Imran, Mehnaz; Chaudary, Nusrat Ijaz; Pervaiz, Hassan; Gallegos, J Alejandro; Alvi, M Imran; Mumtaz, Muhammad; Gezer, Sefer; Venugopal, Parameswaran; Reddy, Poluru; Galili, Naomi; Candoni, Anna; Singer, Jack; Nucifora, Giuseppina.

Leuk Res ; 28(8): 791-803, 2004 Aug.

Article in English | MEDLINE | ID: mdl-15203277

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: